New research by Dr. Liisa Galea, at the University of British Columbia, suggests the form of estrogens used in hormone therapy and that occur in motherhood could be critical to explaining why hormone therapy has variable effects.
Newsroom
For media enquiries or to connect with researchers in the MacVicar Lab at the Djavad Mowafaghian Centre for Brain Health, please contact Emily Wight, Communications Manager.
- Email: emily.wight@brain.ubc.ca
- Phone: 604-417-0165
For general enquiries about MacVicar Lab activities, please contact Katherine Rhodes at krhodes@brain.ubc.ca.
The Canadian Association for Neuroscience, Djavad Mowafaghian Centre for Brain Health and Science World have teamed up to present latest neuroscience research to the public.
Researchers at the Djavad Mowafaghian Centre for Brain Health say a new epilepsy drug holds promise as a treatment for Alzheimer’s disease.
Acknowledging the influence of female physiology is essential to providing effective, individualized treatment.
Pictured: Dr. Terrance Snutch (left) and Dr. Brian MacVicar (right)
A team of researchers has made a significant discovery in the mechanism of brain swelling, paving the way to preventative treatment for severe to fatal brain damage following stroke, head injury or cardiac arrest. Their research, published today in Cell, paves the way for a preventative drug treatment for severe brain damage following stroke, infection, head injury or cardiac arrest.
A collaborative, interdisciplinary project from researchers at the Djavad Mowafaghian Centre for Brain Health is making it possible to watch brain stimulation in action.
Vancouver Coastal Health Research Institute (VCHRI) is proud to name the recipients of the 2015 Top Graduating Doctoral Student Awards and the Rising Star Awards.
The Honourable Ed Holder, Minister of State (Science and Technology) announced 150 new and renewed Canada Research Chairs, including six members of the Djavad Mowafaghian Centre for Brain Health.
A major study that will provide in-depth understanding of aging for decades has received a shot in the arm. The Canadian Longitudinal Study on Aging (CLSA) has received a $41.6 million grant through the Government of Canada to continue its work for the next five years.
